Kevin Sweet
Biochemistry, Genetics and Molecular Biology · The Ohio State University
Publications
132
Citations
3,972
Est. group size
~3
Recurring co-author estimate
Active years
36
Publishing since 1991
This researcher studies inherited cancer risk, focusing on genetic mutations such as BRCA1, BRCA2, MUTYH, and NTHL1 that predispose people to breast, ovarian, and colorectal cancers, as well as rare tumors like desmoid tumors and sarcomas. Work spans clinical genetics, cancer risk management (such as preventive surgery), and tumor mutation profiling to improve diagnosis and treatment decisions. The research combines molecular analysis with clinical outcome studies involving patient cohorts.
Publication output has fluctuated over the last decade, with a notable spike in 2023 followed by a return to more modest annual output in 2024-2025.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Continuous deep sedation versus minimal sedation after cardiac arrest and resuscitation (<scp>SED</scp>‐<scp>CARE</scp>): A protocol for a randomized clinical trial
Acta Anaesthesiologica Scandinavica · 2025
- Adenomas from individuals with pathogenic biallelic variants in the MUTYH and NTHL1 genes demonstrate base excision repair tumour mutational signature profiles similar to colorectal cancers, expanding potential diagnostic and variant classification applications
Translational Oncology · 2025
- Bilateral Oophorectomy and All-Cause Mortality in Women With <i>BRCA1</i> and <i>BRCA2</i> Sequence Variations
JAMA Oncology · 2024
- Adenomas from individuals with pathogenic biallelic variants in the <i>MUTYH</i> and <i>NTHL1</i> genes demonstrate base excision repair tumour mutational signature profiles similar to colorectal cancers, expanding potential diagnostic and variant classification applications
medRxiv · 2024
- Personal finance tips for the early career radiologist and beyond
Abdominal Radiology · 2024
- Adenomas from Individuals with Pathogenic Biallelic Variants in the Mutyh and Nthl1 Genes Demonstrate Base Excision Repair Tumour Mutational Signature Profiles Similar to Colorectal Cancers, Expanding Potential Diagnostic and Variant Classification Applications
SSRN Electronic Journal · 2024
- Tamoxifen and the risk of breast cancer in women with a BRCA1 or BRCA2 mutation
Breast Cancer Research and Treatment · 2023
- Assessing the general public’s view of direct-to-consumer (DTC) genetic testing and their interpretation of DTC website disclaimer messages
European Journal of Human Genetics · 2023
- Data from Systemic Chemotherapies Retain Antitumor Activity in Desmoid Tumors Independent of Specific Mutations in <i>CTNNB1</i> or <i>APC</i>: A Multi-institutional Retrospective Study
2023
- Supplementary Data from Systemic Chemotherapies Retain Antitumor Activity in Desmoid Tumors Independent of Specific Mutations in <i>CTNNB1</i> or <i>APC</i>: A Multi-institutional Retrospective Study
2023
- Supplementary Figure from Systemic Chemotherapies Retain Antitumor Activity in Desmoid Tumors Independent of Specific Mutations in <i>CTNNB1</i> or <i>APC</i>: A Multi-institutional Retrospective Study
2023
- Supplementary Figure from Systemic Chemotherapies Retain Antitumor Activity in Desmoid Tumors Independent of Specific Mutations in <i>CTNNB1</i> or <i>APC</i>: A Multi-institutional Retrospective Study
2023
- Data from Systemic Chemotherapies Retain Antitumor Activity in Desmoid Tumors Independent of Specific Mutations in <i>CTNNB1</i> or <i>APC</i>: A Multi-institutional Retrospective Study
2023
- Supplementary Figure from Systemic Chemotherapies Retain Antitumor Activity in Desmoid Tumors Independent of Specific Mutations in <i>CTNNB1</i> or <i>APC</i>: A Multi-institutional Retrospective Study
2023
- Supplementary Figure from Systemic Chemotherapies Retain Antitumor Activity in Desmoid Tumors Independent of Specific Mutations in <i>CTNNB1</i> or <i>APC</i>: A Multi-institutional Retrospective Study
2023
- British Journal of Cancer×3
- Journal of Genetic Counseling×3
- Breast Cancer Research and Treatment×3
- JAMA Oncology×2
- Journal of Clinical Oncology×2
- Lindsey Byrne
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Amanda E. Toland
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Na Li
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Kate Shane-Carson
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Leigha Senter
Biochemistry, Genetics and Molecular Biology · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile